uh oh david healy good news smithklinebeecham manufacturer paroxetine paxil healy colleagues utilized data sources latest article plos medicine data submitted glaxosmithkline paroxetine review committee safety medicines expert working group data united kingdom drug safety research unit dsru prescription event monitoring studies paroxetine fluoxetine legal cases authors given evidence admittedly little shakier though still interest mails patients response bbc programme paroxetine broadcast find let focus data type post clinical trial data provided manufacturer participants taking paxil significantly likely show hostility odds ratio following data comes trials included previous bullet point data sertraline paediatric trials submitted pfizer aggression joint commonest cause discontinuation two sertraline placebo controlled trials depressed children trials eight patients randomised sertraline discontinued aggression agitation hyperkinesis coding term akathisia compared dropouts reasons patients placebo ci infinity discontinuations manifestation treatment induced activation suicidal ideation attempts aggression agitation hyperkinesis aggravated depression considered discontinuations sertraline compared two placebo relative risk ci p p limited data healthy volunteers suggests increased hostility among people taking paroxetine link akathisia induced occasion antidepressants aggression well suicide explored summary certainly much article i describe like data three sources admittedly falls well short smoking gun nicely summarizes research topic close eye paroxetine evidence continues slowly trickle often inconsistent certainly enough data suggest least insist full disclosure data clinical trials warn possible aggression suicidality side effects monitor patients aggression suicidality quite closely oh use psychotherapy first better results long term many fewer side effects full text article